According to Intra-Cellular Therapies's latest financial reports and stock price the company's current number of shares outstanding is 96,875,275. At the end of 2024 the company had 96,875,275 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2024 | 96.87 M | 0.61% |
2023 | 96.28 M | 1.62% |
2022 | 94.75 M | 16.29% |
2021 | 81.47 M | 1.47% |
2020 | 80.29 M | 45.26% |
2019 | 55.27 M | 0.96% |
2018 | 54.75 M | 0.63% |
2017 | 54.4 M | 25.73% |
2016 | 43.27 M | 0.51% |
2015 | 43.05 M | 46.28% |
2014 | 29.43 M | 32.82% |
2013 | 22.15 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Xencor XNCR | 61,212,324 | -36.81% | ๐บ๐ธ USA |
MediciNova MNOV | 49,046,246 | -49.37% | ๐บ๐ธ USA |
Curis CRIS | 5,783,585 | -94.03% | ๐บ๐ธ USA |